|
FAM53C expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.215600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.996300E-02 |
| Normal-vs-Stage2 |
5.657400E-01 |
| Normal-vs-Stage3 |
7.780600E-01 |
| Normal-vs-Stage4 |
7.911000E-01 |
| Stage1-vs-Stage2 |
3.979200E-01 |
| Stage1-vs-Stage3 |
6.426200E-02 |
| Stage1-vs-Stage4 |
2.029500E-02 |
| Stage2-vs-Stage3 |
6.906400E-01 |
| Stage2-vs-Stage4 |
3.879000E-01 |
| Stage3-vs-Stage4 |
5.423000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.510200E-01 |
| Normal-vs-AfricanAmerican |
3.852600E-01 |
| Normal-vs-Asian |
9.665800E-01 |
| Caucasian-vs-AfricanAmerican |
8.607800E-01 |
| Caucasian-vs-Asian |
7.704800E-01 |
| AfricanAmerican-vs-Asian |
7.204000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.163800E-01 |
| Normal-vs-Female |
8.936300E-02 |
| Male-vs-Female |
5.736400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.230200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.688240E-01 |
| Normal-vs-Age(61-80Yrs) |
6.113800E-01 |
| Normal-vs-Age(81-100Yrs) |
2.224600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.112150E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.772200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.694370E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.218600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.853800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.948000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.237800E-02 |
| Normal-vs-Grade 2 |
1.588640E-01 |
| Normal-vs-Grade 3 |
6.081200E-01 |
| Normal-vs-Grade 4 |
6.504400E-01 |
| Grade 1-vs-Grade 2 |
7.237600E-02 |
| Grade 1-vs-Grade 3 |
4.321700E-02 |
| Grade 1-vs-Grade 4 |
2.293800E-02 |
| Grade 2-vs-Grade 3 |
2.360400E-01 |
| Grade 2-vs-Grade 4 |
1.890410E-02 |
| Grade 3-vs-Grade 4 |
2.305000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.583600E-02 |
| Normal-vs-ccB subtype |
8.790600E-01 |
| ccA subtype-vs-ccB subtype |
7.643400E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.509400E-01 |
| Normal-vs-N1 |
5.219000E-01 |
| N0-vs-N1 |
8.321600E-01 |
|
|
